Provigil - Modafinil Information

Provigil - Modafinil Information » Nuvigil http://www.provigil-rx.info The Ultimate Provigil/Modafinil Information Resource - Aggregated & Updated Daily Fri, 03 Feb 2012 15:17:01 +0000 http://wordpress.org/?v=2.8.5 en hourly 1 States of mind – PennLive.com http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHJ-QpXDXSNjL27KdTtWc5Sgh4hxw&url=http://www.pennlive.com/bodyandmind/index.ssf/2012/02/states_of_mind.html http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHJ-QpXDXSNjL27KdTtWc5Sgh4hxw&url=http://www.pennlive.com/bodyandmind/index.ssf/2012/02/states_of_mind.html#comments Wed, 01 Feb 2012 05:14:14 +0000 admin tag:news.google.com,2005:cluster=http://www.pennlive.com/bodyandmind/index.ssf/2012/02/states_of_mind.html

States of mind
PennLive.com
Some drugs used include Ritalin, most commonly used to treat symptoms of attention deficit hyperactivity disorder; Amantadine, a Parkinson's disease drug; and NUVIGIL, a treatment for narcolepsy. Dr. Nicholas Schiff, director of the Laboratory of ...

]]>

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHJ-QpXDXSNjL27KdTtWc5Sgh4hxw&url=http://www.pennlive.com/bodyandmind/index.ssf/2012/02/states_of_mind.html/feed/ 0 PM360 Announces Winners of Pharma Choice Awards – PR Web (press release) http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHp2Ab4grDRzRKwi_IDx9tMQsGBrQ&url=http://www.prweb.com/releases/2012/1/prweb9131779.htm http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHp2Ab4grDRzRKwi_IDx9tMQsGBrQ&url=http://www.prweb.com/releases/2012/1/prweb9131779.htm#comments Wed, 25 Jan 2012 08:43:14 +0000 admin tag:news.google.com,2005:cluster=http://www.prweb.com/releases/2012/1/prweb9131779.htm

PM360 Announces Winners of Pharma Choice Awards
PR Web (press release)
Agency: Rosetta BRONZE: Nuvigil Proud Sponsor HCP Mobile Site for Cephalon, Inc. Agency: Draftfcb Healthcare GOLD: Klick Health 2010 Holiday Video for Klick Health. Agency: Klick Health SILVER: AbelsonTaylor Mobile Web site for AbelsonTaylor.

]]>

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHp2Ab4grDRzRKwi_IDx9tMQsGBrQ&url=http://www.prweb.com/releases/2012/1/prweb9131779.htm/feed/ 0 שלושה גורמים שעלולים לשבש את תחזיותיה של טבע ב-2012 – The Marker http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEx32NPiXnJFt2YgyVQp_G7P9YMyA&url=http://www.themarker.com/markets/1.1600213?%3D http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEx32NPiXnJFt2YgyVQp_G7P9YMyA&url=http://www.themarker.com/markets/1.1600213?%3D#comments Sun, 25 Dec 2011 05:02:18 +0000 admin tag:news.google.com,2005:cluster=http://www.themarker.com/markets/1.1600213?=

שלושה גורמים שעלולים לשבש את תחזיותיה של טבע ב-2012
The Marker
... הוא מינוף תיק התרופות המקוריות של ספלון לאזורים גיאוגרפיים נוספים, כמו יפאן ואירופה; וכן פיתוח צנרת המוצרים שנרכשה עם ספלון, ושבה 30 תרופות בשלבי פיתוח מתקדמים, למשל הצלחה בניסוי בתרופה Nuvigil, שתאפשר את הרחבת השימוש בה מהפרעות שינה למאניה דפרסיה.

and more »

]]>

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEx32NPiXnJFt2YgyVQp_G7P9YMyA&url=http://www.themarker.com/markets/1.1600213?%3D/feed/ 0 Jefferies Sees Favorable Copaxone Ruling is Only Catalyst to Move Shares of … – StreetInsider.com (subscription) http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEF5KYOBI40-gZIUWhDI6AhOuRnlw&url=http://www.streetinsider.com/Analyst%2BComments/Jefferies%2BSees%2BFavorable%2BCopaxone%2BRuling%2Bis%2BOnly%2BCatalyst%2Bto%2BMove%2BShares%2Bof%2BTeva%2BPharm%2B(TEVA)/7041135.html http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEF5KYOBI40-gZIUWhDI6AhOuRnlw&url=http://www.streetinsider.com/Analyst%2BComments/Jefferies%2BSees%2BFavorable%2BCopaxone%2BRuling%2Bis%2BOnly%2BCatalyst%2Bto%2BMove%2BShares%2Bof%2BTeva%2BPharm%2B(TEVA)/7041135.html#comments Fri, 23 Dec 2011 12:48:26 +0000 admin tag:news.google.com,2005:cluster=http://www.streetinsider.com/Analyst+Comments/Jefferies+Sees+Favorable+Copaxone+Ruling+is+Only+Catalyst+to+Move+Shares+of+Teva+Pharm+(TEVA)/7041135.html

Jefferies Sees Favorable Copaxone Ruling is Only Catalyst to Move Shares of ...
StreetInsider.com (subscription)
Teva's confirmation that a new drug application filing for Nuvigil would be done in 2012, and that the three Phase 3 trials will start to read out in Q1 is exciting for the company's outlook. The firm views it as a strong asset in its pipeline and ...

and more »

]]>

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEF5KYOBI40-gZIUWhDI6AhOuRnlw&url=http://www.streetinsider.com/Analyst%2BComments/Jefferies%2BSees%2BFavorable%2BCopaxone%2BRuling%2Bis%2BOnly%2BCatalyst%2Bto%2BMove%2BShares%2Bof%2BTeva%2BPharm%2B(TEVA)/7041135.html/feed/ 0 Report: Doctor arrested in pill mill case tried to enter jail with contraband – Tampabay.com http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFOiHHAhsVTHYzplcFYz8wgFhqDrA&url=http://www.tampabay.com/news/briefs/report-doctor-arrested-in-pill-mill-case-tried-to-enter-jail-with/1206281 http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFOiHHAhsVTHYzplcFYz8wgFhqDrA&url=http://www.tampabay.com/news/briefs/report-doctor-arrested-in-pill-mill-case-tried-to-enter-jail-with/1206281#comments Wed, 14 Dec 2011 23:57:39 +0000 admin tag:news.google.com,2005:cluster=http://www.tampabay.com/news/briefs/report-doctor-arrested-in-pill-mill-case-tried-to-enter-jail-with/1206281

Report: Doctor arrested in pill mill case tried to enter jail with contraband
Tampabay.com
... a report says the doctor had a wee pharmacy hidden on him: one pill of Tizandine, a muscle relaxer; one Prilosec, for heartburn relief; half of a Viagra pill, for treatment of erectile dysfunction; and 1 1/2 pills of Nuvigil, a stimulant. ...

and more »

]]>

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFOiHHAhsVTHYzplcFYz8wgFhqDrA&url=http://www.tampabay.com/news/briefs/report-doctor-arrested-in-pill-mill-case-tried-to-enter-jail-with/1206281/feed/ 0 Teva jacks up prices on Cephalon legacy brands – FiercePharma http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHFXrCcwnSu56P89jE-ZsNMBkkbLQ&url=http://www.fiercepharma.com/story/teva-jacks-prices-cephalon-legacy-brands/2011-12-07 http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHFXrCcwnSu56P89jE-ZsNMBkkbLQ&url=http://www.fiercepharma.com/story/teva-jacks-prices-cephalon-legacy-brands/2011-12-07#comments Wed, 07 Dec 2011 16:54:56 +0000 admin tag:news.google.com,2005:cluster=http://www.fiercepharma.com/story/teva-jacks-prices-cephalon-legacy-brands/2011-12-07

Teva jacks up prices on Cephalon legacy brands
FiercePharma
Citing a wholesale pricing report from Medi-Span, Deutsche Bank analysts say Teva hiked the prices on Cephalon painkiller Fentora and wakefulness drug Provigil 15%--and raised the price on Provigil follow-up Nuvigil 25%. The latter increase came on top ...
Teva raises Cephalon drug prices up to 25% - reportGlobes

all 5 news articles »

]]>

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHFXrCcwnSu56P89jE-ZsNMBkkbLQ&url=http://www.fiercepharma.com/story/teva-jacks-prices-cephalon-legacy-brands/2011-12-07/feed/ 0 Bipolar Disorder Therapeutics – Pipeline Assessment and Market Forecasts to 2018 – Sacramento Bee http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE85-OOrA2zL4QzAcfIwsl4HTG6WA&url=http://www.sacbee.com/2011/10/27/4010336/bipolar-disorder-therapeutics.html http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE85-OOrA2zL4QzAcfIwsl4HTG6WA&url=http://www.sacbee.com/2011/10/27/4010336/bipolar-disorder-therapeutics.html#comments Thu, 27 Oct 2011 12:21:04 +0000 admin tag:news.google.com,2005:cluster=http://www.sacbee.com/2011/10/27/4010336/bipolar-disorder-therapeutics.html

Bipolar Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Sacramento Bee
In addition to this, pipeline molecules such as cariprazine, Nuvigil (armodafinil), and Latuda (lurasidone hydrochloride) are expected to be launched in 2013. GlobalData expects that these factors will account for positive growth within the bipolar ...

and more »

]]>

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE85-OOrA2zL4QzAcfIwsl4HTG6WA&url=http://www.sacbee.com/2011/10/27/4010336/bipolar-disorder-therapeutics.html/feed/ 0 Bipolar Disorder Therapeutics – Pipeline Assessment and Market Forecasts to 2018 – Virtual Press Office (press release) http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEtSMklsVMNJ05vl7xvi6CojLTrQA&url=http://www.virtualpressoffice.com/publicsiteContentFileAccess?fileContentId%3D628617%26fromOtherPageToDisableHistory%3DY%26menuName%3DNews%26sId%3D%26sInfo%3D http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEtSMklsVMNJ05vl7xvi6CojLTrQA&url=http://www.virtualpressoffice.com/publicsiteContentFileAccess?fileContentId%3D628617%26fromOtherPageToDisableHistory%3DY%26menuName%3DNews%26sId%3D%26sInfo%3D#comments Thu, 27 Oct 2011 09:18:11 +0000 admin tag:news.google.com,2005:cluster=http://www.virtualpressoffice.com/publicsiteContentFileAccess?fileContentId=628617&fromOtherPageToDisableHistory=Y&menuName=News&sId=&sInfo=

Bipolar Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Virtual Press Office (press release)
In addition to this, pipeline molecules such as cariprazine, Nuvigil (armodafinil), and Latuda (lurasidone hydrochloride) are expected to be launched in 2013. GlobalData expects that these factors will account for positive growth within the bipolar ...

and more »

]]>

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEtSMklsVMNJ05vl7xvi6CojLTrQA&url=http://www.virtualpressoffice.com/publicsiteContentFileAccess?fileContentId%3D628617%26fromOtherPageToDisableHistory%3DY%26menuName%3DNews%26sId%3D%26sInfo%3D/feed/ 0 Bipolar Disorder Therapeutics – Pipeline Assessment and Market Forecasts to 2018 – MarketWatch (press release) http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEeJbUrwltg4In_GYE3jNafAc-n_g&url=http://www.marketwatch.com/story/bipolar-disorder-therapeutics-pipeline-assessment-and-market-forecasts-to-2018-2011-10-27 http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEeJbUrwltg4In_GYE3jNafAc-n_g&url=http://www.marketwatch.com/story/bipolar-disorder-therapeutics-pipeline-assessment-and-market-forecasts-to-2018-2011-10-27#comments Thu, 27 Oct 2011 08:27:40 +0000 admin tag:news.google.com,2005:cluster=http://www.marketwatch.com/story/bipolar-disorder-therapeutics-pipeline-assessment-and-market-forecasts-to-2018-2011-10-27

Bipolar Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018
MarketWatch (press release)
In addition to this, pipeline molecules such as cariprazine, Nuvigil (armodafinil), and Latuda (lurasidone hydrochloride) are expected to be launched in 2013. GlobalData expects that these factors will account for positive growth within the bipolar ...

and more »

]]>

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEeJbUrwltg4In_GYE3jNafAc-n_g&url=http://www.marketwatch.com/story/bipolar-disorder-therapeutics-pipeline-assessment-and-market-forecasts-to-2018-2011-10-27/feed/ 0 Bipolar Disorder Therapeutics – Pipeline Assessment and Market Forecasts to 2018 – PR Newswire (press release) http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNG1RKeVaIFrMLrG6yzE8fBZzpTqsA&url=http://www.prnewswire.com/news-releases/bipolar-disorder-therapeutics---pipeline-assessment-and-market-forecasts-to-2018-132680433.html http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNG1RKeVaIFrMLrG6yzE8fBZzpTqsA&url=http://www.prnewswire.com/news-releases/bipolar-disorder-therapeutics---pipeline-assessment-and-market-forecasts-to-2018-132680433.html#comments Thu, 27 Oct 2011 08:27:30 +0000 admin tag:news.google.com,2005:cluster=http://www.prnewswire.com/news-releases/bipolar-disorder-therapeutics---pipeline-assessment-and-market-forecasts-to-2018-132680433.html

Bipolar Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2018
PR Newswire (press release)
In addition to this, pipeline molecules such as cariprazine, Nuvigil (armodafinil), and Latuda (lurasidone hydrochloride) are expected to be launched in 2013. GlobalData expects that these factors will account for positive growth within the bipolar ...

and more »

]]>

]]> http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNG1RKeVaIFrMLrG6yzE8fBZzpTqsA&url=http://www.prnewswire.com/news-releases/bipolar-disorder-therapeutics---pipeline-assessment-and-market-forecasts-to-2018-132680433.html/feed/ 0